Literature DB >> 29796862

Molecular profiling of mucosal tissue associated microbiota in patients manifesting acute exacerbations and remission stage of ulcerative colitis.

Sandeep A Walujkar1,2,3, Shreyas V Kumbhare1, Nachiket P Marathe1,4, Dhrati V Patangia1, Parimal S Lawate5, Renu S Bharadwaj2, Yogesh S Shouche6.   

Abstract

Dysbiosis of intestinal microflora has been postulated in ulcerative colitis (UC), which is characterized by imbalance of mucosal tissue associated bacterial communities. However, the specific changes in mucosal microflora during different stages of UC are still unknown. The aim of the current study was to investigate the changes in mucosal tissue associated microbiota during acute exacerbations and remission stages of UC. The mucosal microbiota associated with colon biopsy of 12 patients suffering from UC (exacerbated stage) and the follow-up samples from the same patients (remission stage) as well as non-IBD subjects was studied using 16S rRNA gene-based sequencing and quantitative PCR. The total bacterial count in patients suffering from exacerbated phase of UC was observed to be two fold lower compared to that of the non-IBD subjects (p = 0.0049, Wilcox on matched-pairs signed rank tests). Bacterial genera including Stenotrophomonas, Parabacteroides, Elizabethkingia, Pseudomonas, Micrococcus, Ochrobactrum and Achromobacter were significantly higher in abundance during exacerbated phase of UC as compared to remission phase. The alterations in bacterial diversity with an increase in the abnormal microbial communities signify the extent of dysbiosis in mucosal microbiota in patients suffering from UC. Our study helps in identifying the specific genera dominating the microbiota during the disease and thus lays a basis for further investigation of the possible role of these bacteria in pathogenesis of UC.

Entities:  

Keywords:  Achromobacter; Dysbiosis; Gut microflora; Mucosal tissue inflammation; Stenotrophomonas; Ulcerative colitis

Mesh:

Substances:

Year:  2018        PMID: 29796862     DOI: 10.1007/s11274-018-2449-0

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  80 in total

Review 1.  Host-gut microbiota metabolic interactions.

Authors:  Jeremy K Nicholson; Elaine Holmes; James Kinross; Remy Burcelin; Glenn Gibson; Wei Jia; Sven Pettersson
Journal:  Science       Date:  2012-06-06       Impact factor: 47.728

Review 2.  Potential role of the intestinal microbiota in programming health and disease.

Authors:  Olivier Goulet
Journal:  Nutr Rev       Date:  2015-08       Impact factor: 7.110

Review 3.  Implications of the human microbiome in inflammatory bowel diseases.

Authors:  Syeda M Bakhtiar; Jean Guy LeBlanc; Emiliano Salvucci; Amjad Ali; Rebeca Martin; Philippe Langella; Jean-Marc Chatel; Anderson Miyoshi; Luis G Bermúdez-Humarán; Vasco Azevedo
Journal:  FEMS Microbiol Lett       Date:  2013-03-15       Impact factor: 2.742

4.  Mucosal flora in inflammatory bowel disease.

Authors:  Alexander Swidsinski; Axel Ladhoff; Annelie Pernthaler; Sonja Swidsinski; Vera Loening-Baucke; Marianne Ortner; Jutta Weber; Uwe Hoffmann; Stefan Schreiber; Manfred Dietel; Herbert Lochs
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

5.  Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease.

Authors:  Shadi Sepehri; Roman Kotlowski; Charles N Bernstein; Denis O Krause
Journal:  Inflamm Bowel Dis       Date:  2007-06       Impact factor: 5.325

6.  Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients.

Authors:  M Lorea Baroja; P V Kirjavainen; S Hekmat; G Reid
Journal:  Clin Exp Immunol       Date:  2007-06-22       Impact factor: 4.330

Review 7.  Short-chain fatty acids in control of body weight and insulin sensitivity.

Authors:  Emanuel E Canfora; Johan W Jocken; Ellen E Blaak
Journal:  Nat Rev Endocrinol       Date:  2015-08-11       Impact factor: 43.330

8.  Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment.

Authors:  Xochitl C Morgan; Timothy L Tickle; Harry Sokol; Dirk Gevers; Kathryn L Devaney; Doyle V Ward; Joshua A Reyes; Samir A Shah; Neal LeLeiko; Scott B Snapper; Athos Bousvaros; Joshua Korzenik; Bruce E Sands; Ramnik J Xavier; Curtis Huttenhower
Journal:  Genome Biol       Date:  2012-04-16       Impact factor: 13.583

9.  Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota.

Authors:  Samah O Noor; Karyn Ridgway; Louise Scovell; E Katherine Kemsley; Elizabeth K Lund; Crawford Jamieson; Ian T Johnson; Arjan Narbad
Journal:  BMC Gastroenterol       Date:  2010-11-12       Impact factor: 3.067

10.  Revised Estimates for the Number of Human and Bacteria Cells in the Body.

Authors:  Ron Sender; Shai Fuchs; Ron Milo
Journal:  PLoS Biol       Date:  2016-08-19       Impact factor: 8.029

View more
  11 in total

1.  Immunity improvement and gut microbiota remodeling of mice by wheat germ globulin.

Authors:  Guanghai Yu; Xiaoguo Ji; Jihong Huang; Aimei Liao; Long Pan; Yinchen Hou; Ming Hui; Weiyun Guo
Journal:  World J Microbiol Biotechnol       Date:  2021-03-18       Impact factor: 3.312

2.  Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.

Authors:  Na Wu; Yu-Qing Feng; Na Lyu; Di Wang; Wei-Dong Yu; Yong-Fei Hu
Journal:  World J Gastroenterol       Date:  2022-05-14       Impact factor: 5.374

3.  Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences.

Authors:  Fatouma Salem; Nadège Kindt; Julian R Marchesi; Patrick Netter; Anthony Lopez; Tunay Kokten; Silvio Danese; Jean-Yves Jouzeau; Laurent Peyrin-Biroulet; David Moulin
Journal:  United European Gastroenterol J       Date:  2019-08-01       Impact factor: 4.623

Review 4.  Systematic Review: The Gut Microbiome and Its Potential Clinical Application in Inflammatory Bowel Disease.

Authors:  Laila Aldars-García; María Chaparro; Javier P Gisbert
Journal:  Microorganisms       Date:  2021-04-30

5.  Intestinal autophagy links psychosocial stress with gut microbiota to promote inflammatory bowel disease.

Authors:  Shu-Ling Wang; Bo-Zong Shao; Sheng-Bing Zhao; Xin Chang; Pei Wang; Chao-Yu Miao; Zhao-Shen Li; Yu Bai
Journal:  Cell Death Dis       Date:  2019-09-30       Impact factor: 8.469

6.  Butyric Acid Increases the Therapeutic Effect of EHLJ7 on Ulcerative Colitis by Inhibiting JAK2/STAT3/SOCS1 Signaling Pathway.

Authors:  Xiaonan Tang; Xiang Li; Yufei Wang; ZhiHui Zhang; AnJun Deng; WenJie Wang; Haijing Zhang; Hailin Qin; LianQiu Wu
Journal:  Front Pharmacol       Date:  2020-01-22       Impact factor: 5.810

7.  Association of Hyperuricemia With Immune Disorders and Intestinal Barrier Dysfunction.

Authors:  Qiulan Lv; Daxing Xu; Xuezhi Zhang; Xiaomin Yang; Peng Zhao; Xuena Cui; Xiu Liu; Wan Yang; Guanpin Yang; Shichao Xing
Journal:  Front Physiol       Date:  2020-11-27       Impact factor: 4.566

Review 8.  An integrated perspective on transmutation of acute inflammation into chronic and the role of the microbiome.

Authors:  George Vithoulkas
Journal:  J Med Life       Date:  2021 Nov-Dec

9.  Gegen Qinlian Decoction Alleviates Experimental Colitis and Concurrent Lung Inflammation by Inhibiting the Recruitment of Inflammatory Myeloid Cells and Restoring Microbial Balance.

Authors:  Yalan Li; Na Li; Jiajing Liu; Tieshan Wang; Ruijuan Dong; Dongyu Ge; Guiying Peng
Journal:  J Inflamm Res       Date:  2022-02-24

10.  The effects of exopolysaccharides and exopolysaccharide-producing Lactobacillus on the intestinal microbiome of zebrafish (Danio rerio).

Authors:  Chenchen Ma; Hongyang Guo; Haibo Chang; Shi Huang; Shuaiming Jiang; Dongxue Huo; Jiachao Zhang; Xiaopeng Zhu
Journal:  BMC Microbiol       Date:  2020-10-06       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.